PUT/MERCK & CO./110/0.1/20.09.24 | Real-time BOERSE MUENCHEN 19:27:20 27/06/2024 BST | ||
| 0.057 EUR | +39.02% |
|
| Current month | -65.25% | ||
| 1 month | -38.81% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 27/06/24 | 0.057 | +39.02% |
| 26/06/24 | 0.041 | +5.13% |
| 25/06/24 | 0.039 | -13.33% |
| 24/06/24 | 0.045 | -11.76% |
| 21/06/24 | 0.051 | 0.00% |
Real-time BOERSE MUENCHEN
Last update June 27, 2024 at 07:27 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GG0N7A |
| ISIN | DE000GG0N7A8 |
| Date issued | 04/12/2023 |
| Strike | 110 $ |
| Maturity | 20/09/2024 (85 Days) |
| Parity | 10 : 1 |
| Emission price | 0.94 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1 € |
|---|---|
| Lowest since issue | 0.038 € |
| Spread | 0.007 € |
| Spread % | 10.61% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5
USD
Average target price
142.7
USD
Spread / Average Target
+8.50%
- Stock Market
- Warrants
- Warrant
